Xanadu Quantum and Crane Harbor File $3.1B Merger Registration Statement
Xanadu Quantum Technologies and Crane Harbor Acquisition Corp. announced the public filing of their joint registration statement on Form F-4 with the U.S. Securities and Exchange Commission in connection with their previously announced $3.1B proposed business combination. The public filing follows the confidential submission of Xanadu Quantum Technologies Limited's initial draft registration statement on November 24, 2025. The Registration Statement, which includes a preliminary proxy statement/prospectus, has not yet been declared effective and remains subject to review and amendment by the SEC. Once declared effective, the Registration Statement will provide important information regarding Xanadu's business, technology, and operations, as well as details of the proposed transaction and the matters to be considered by shareholders of Crane Harbor. Xanadu, Crane Harbor and a newly formed entity, Xanadu Quantum Technologies Limited, entered into a definitive business combination agreement on November 3, 2025. The proposed transaction is expected to close in the first quarter of 2026, subject to the Registration Statement being declared effective by the SEC, the approval by Crane Harbor and Xanadu shareholders, and the satisfaction of other customary closing conditions.
Trade with 70% Backtested Accuracy
Analyst Views on CHAC
About CHAC
About the author
Xanadu Develops Quantum Framework to Accelerate Cancer Drug Discovery
- Quantum Computing Breakthrough: Xanadu's newly developed quantum computational framework demonstrates the potential of quantum computers to accelerate the discovery of cancer treatment drugs by simulating four diverse photosensitizers, significantly enhancing research efficiency and potentially transforming the future of cancer therapy.
- Cost and Time Optimization: This framework addresses the high costs and lengthy durations associated with traditional experimental synthesis and classical simulations, making the identification of drug candidates more efficient, thereby advancing cancer treatment progress.
- Business Combination Prospects: The merger with Crane Harbor Acquisition Corp. is expected to yield approximately $500 million in funding, strengthening the new company's capital base and facilitating further advancements in the quantum computing sector.
- Market Strategic Positioning: By applying quantum computing, Xanadu not only provides new insights for drug design but also opens up new possibilities for future cancer treatments, highlighting its strategic significance in the biopharmaceutical field.
Xanadu Signs MoU with A*STAR for Quantum Technology Collaboration
- Collaboration Expansion: Xanadu has signed a Memorandum of Understanding with Singapore's ASTAR to advance research in quantum technologies, combining Xanadu's expertise in photonic quantum computing with ASTAR's research capabilities, thereby enhancing Singapore's competitiveness in the global quantum technology landscape.
- Research Focus: The collaboration will target projects such as the development of quantum light sources and quantum connectivity, which is expected to accelerate the practical application of quantum computers to meet the growing demand across various industries for quantum technology.
- Funding Support: The business combination with Crane Harbor is projected to yield approximately $500 million in funding, including $225 million from Crane Harbor's trust account and $275 million from strategic investors, significantly bolstering Xanadu's investment capacity in quantum technology.
- Market Outlook: This partnership not only fosters innovation in quantum technology in Singapore but also provides Xanadu with broader market opportunities, positioning it to lead in the rapidly evolving quantum computing market.
Essential Quantum Computing Stock Update for IonQ, Rigetti Computing, and D-Wave Investors
Xanadu's Merger Plans: Xanadu Quantum Technologies is set to merge with Crane Harbor in a SPAC deal, aiming to become the first public pure play photonic quantum computing company by the first half of 2026.
Quantum Supremacy Achievement: The company achieved quantum supremacy in 2022 with its Borealis system, solving complex problems significantly faster than classical supercomputers.
PennyLane Software: Xanadu has developed PennyLane, an open-source quantum programming platform that is widely adopted, potentially offering significant monetization opportunities.
Investor Speculation: As Xanadu prepares for its public debut, investors may shift their focus from other quantum computing stocks like IonQ and Rigetti Computing, which could lead to fluctuations in their stock prices.
Xanadu Progresses to Stage B of DARPA's Quantum Benchmarking Initiative, Obtaining Up to $15 Million in Funding
Xanadu's Progress in Quantum Computing: Xanadu Quantum Technologies has advanced to Stage B of DARPA's Quantum Benchmarking Initiative, showcasing its potential for utility-scale quantum computing and emphasizing its photonic approach.
Business Combination Announcement: The company has entered a business combination agreement with Crane Harbor Acquisition Corp., expected to yield approximately $500 million in gross proceeds, facilitating its listing on Nasdaq and the Toronto Stock Exchange.
Photonic Quantum Computing Advantages: Xanadu's photonic quantum computing architecture offers benefits such as room-temperature operations, improved qubit connectivity, and a modular design, with its Aurora system serving as a proof-of-concept.
Future Plans and Risks: During Stage B, Xanadu will outline its strategies for developing a fault-tolerant quantum computer by 2029, while also addressing potential risks and challenges associated with its technology and market acceptance.
$HAREHOLDER NOTICE: M&A Class Action Firm Launches Investigation into Crane Harbor Acquisition Corp. (NASDAQ: CHAC)
Class Action Firm Recognition: Monteverde & Associates PC, led by attorney Juan Monteverde, is recognized as a Top 50 Firm in the 2024 ISS Securities Class Action Services Report and has successfully recovered millions for shareholders.
Investigation of Crane Harbor Acquisition Corp.: The firm is currently investigating Crane Harbor Acquisition Corp. regarding its merger with Xanadu Quantum Technologies Inc., focusing on the fairness of the deal for shareholders.
Free Consultation Offer: Monteverde & Associates offers free consultations for shareholders concerned about the merger, emphasizing that there is no cost or obligation involved.
Firm's Track Record: The firm, based in the Empire State Building, has a strong history of litigating and recovering funds for shareholders, including cases that have reached the U.S. Supreme Court.
Quantum Stocks Drop as Competitor Xanadu Pursues U.S. Listing
Xanadu's U.S. Listing Announcement: Shares of American quantum computing firms, including IonQ, Rigetti, D-Wave, and Quantum Computing, fell after Xanadu announced plans for a U.S. listing via a $3.6 billion SPAC deal, expected to raise nearly $500 million.
Xanadu's Photonic Technology: Xanadu's quantum computers utilize light particles (photons) for calculations, claiming advantages over competitors that use trapped ions or superconducting qubits, with a focus on scalability and error resistance.
Innovations in Quantum Computing: Xanadu's X-Series is the first photonic quantum computer available on the cloud, featuring error-resistant qubits that enhance stability and reliability, moving quantum computing closer to practical applications.
Analyst Ratings: Wall Street analysts have given a "Strong Buy" consensus rating to D-Wave Quantum and IonQ, with IonQ showing greater upside potential compared to D-Wave.
Xanadu Develops Quantum Framework to Accelerate Cancer Drug Discovery
- Quantum Computing Breakthrough: Xanadu's newly developed quantum computational framework demonstrates the potential of quantum computers to accelerate the discovery of cancer treatment drugs by simulating four diverse photosensitizers, significantly enhancing research efficiency and potentially transforming the future of cancer therapy.
- Cost and Time Optimization: This framework addresses the high costs and lengthy durations associated with traditional experimental synthesis and classical simulations, making the identification of drug candidates more efficient, thereby advancing cancer treatment progress.
- Business Combination Prospects: The merger with Crane Harbor Acquisition Corp. is expected to yield approximately $500 million in funding, strengthening the new company's capital base and facilitating further advancements in the quantum computing sector.
- Market Strategic Positioning: By applying quantum computing, Xanadu not only provides new insights for drug design but also opens up new possibilities for future cancer treatments, highlighting its strategic significance in the biopharmaceutical field.
Xanadu Signs MoU with A*STAR for Quantum Technology Collaboration
- Collaboration Expansion: Xanadu has signed a Memorandum of Understanding with Singapore's ASTAR to advance research in quantum technologies, combining Xanadu's expertise in photonic quantum computing with ASTAR's research capabilities, thereby enhancing Singapore's competitiveness in the global quantum technology landscape.
- Research Focus: The collaboration will target projects such as the development of quantum light sources and quantum connectivity, which is expected to accelerate the practical application of quantum computers to meet the growing demand across various industries for quantum technology.
- Funding Support: The business combination with Crane Harbor is projected to yield approximately $500 million in funding, including $225 million from Crane Harbor's trust account and $275 million from strategic investors, significantly bolstering Xanadu's investment capacity in quantum technology.
- Market Outlook: This partnership not only fosters innovation in quantum technology in Singapore but also provides Xanadu with broader market opportunities, positioning it to lead in the rapidly evolving quantum computing market.
Essential Quantum Computing Stock Update for IonQ, Rigetti Computing, and D-Wave Investors
Xanadu's Merger Plans: Xanadu Quantum Technologies is set to merge with Crane Harbor in a SPAC deal, aiming to become the first public pure play photonic quantum computing company by the first half of 2026.
Quantum Supremacy Achievement: The company achieved quantum supremacy in 2022 with its Borealis system, solving complex problems significantly faster than classical supercomputers.
PennyLane Software: Xanadu has developed PennyLane, an open-source quantum programming platform that is widely adopted, potentially offering significant monetization opportunities.
Investor Speculation: As Xanadu prepares for its public debut, investors may shift their focus from other quantum computing stocks like IonQ and Rigetti Computing, which could lead to fluctuations in their stock prices.
Xanadu Progresses to Stage B of DARPA's Quantum Benchmarking Initiative, Obtaining Up to $15 Million in Funding
Xanadu's Progress in Quantum Computing: Xanadu Quantum Technologies has advanced to Stage B of DARPA's Quantum Benchmarking Initiative, showcasing its potential for utility-scale quantum computing and emphasizing its photonic approach.
Business Combination Announcement: The company has entered a business combination agreement with Crane Harbor Acquisition Corp., expected to yield approximately $500 million in gross proceeds, facilitating its listing on Nasdaq and the Toronto Stock Exchange.
Photonic Quantum Computing Advantages: Xanadu's photonic quantum computing architecture offers benefits such as room-temperature operations, improved qubit connectivity, and a modular design, with its Aurora system serving as a proof-of-concept.
Future Plans and Risks: During Stage B, Xanadu will outline its strategies for developing a fault-tolerant quantum computer by 2029, while also addressing potential risks and challenges associated with its technology and market acceptance.
$HAREHOLDER NOTICE: M&A Class Action Firm Launches Investigation into Crane Harbor Acquisition Corp. (NASDAQ: CHAC)
Class Action Firm Recognition: Monteverde & Associates PC, led by attorney Juan Monteverde, is recognized as a Top 50 Firm in the 2024 ISS Securities Class Action Services Report and has successfully recovered millions for shareholders.
Investigation of Crane Harbor Acquisition Corp.: The firm is currently investigating Crane Harbor Acquisition Corp. regarding its merger with Xanadu Quantum Technologies Inc., focusing on the fairness of the deal for shareholders.
Free Consultation Offer: Monteverde & Associates offers free consultations for shareholders concerned about the merger, emphasizing that there is no cost or obligation involved.
Firm's Track Record: The firm, based in the Empire State Building, has a strong history of litigating and recovering funds for shareholders, including cases that have reached the U.S. Supreme Court.
Quantum Stocks Drop as Competitor Xanadu Pursues U.S. Listing
Xanadu's U.S. Listing Announcement: Shares of American quantum computing firms, including IonQ, Rigetti, D-Wave, and Quantum Computing, fell after Xanadu announced plans for a U.S. listing via a $3.6 billion SPAC deal, expected to raise nearly $500 million.
Xanadu's Photonic Technology: Xanadu's quantum computers utilize light particles (photons) for calculations, claiming advantages over competitors that use trapped ions or superconducting qubits, with a focus on scalability and error resistance.
Innovations in Quantum Computing: Xanadu's X-Series is the first photonic quantum computer available on the cloud, featuring error-resistant qubits that enhance stability and reliability, moving quantum computing closer to practical applications.
Analyst Ratings: Wall Street analysts have given a "Strong Buy" consensus rating to D-Wave Quantum and IonQ, with IonQ showing greater upside potential compared to D-Wave.
